Arkolith/Insider Trading/BIOR/Form 4

dEsparbes Eric

Chief Financial OfficerBIORA THERAPEUTICS, INC. (BIOR) · full profile →Form 4 · filed May 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2022Tax withholding(F)10K$0.75$8K413K
May 15, 2022Grant(A)292K—$0705K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2022Grant(A)472K—$0472K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-018428) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML